Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. (Q37923305)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

review article

1 reference

title

Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

main subject

bronchiolitis

0 references

bronchiolitis obliterans

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Klaus Müller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

H H Uhlving

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

F Buchvald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

C J Heilmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Gormsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

29 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1020-1029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874057%20AND%20SRC:MED&resulttype=core&format=json

Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Development of a prognostic model for grading chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Local IL-17 production and a decrease in peripheral blood regulatory T cells in an animal model of bronchiolitis obliterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

IL-17 as a potential target for modulating airway neutrophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

The dynamics and associations of airway neutrophilia post lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Obliterative bronchiolitis following lung transplantation: from old to new concepts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Induction of obliterative airway disease by anti-HLA class I antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Lung function and late pulmonary complications among survivors of hematopoietic stem cell transplantation during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Imatinib for refractory chronic graft-versus-host disease with fibrotic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Wo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Task force on chronic interstitial lung disease in immunocompetent children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Rituximab for steroid-refractory chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Risk factors for airflow obstruction in recipients of bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT--a randomized double-blinded placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Chronic interstitial lung disease in children: response to high-dose intravenous methylprednisolone pulses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Sinus bradycardia after intravenous pulse methylprednisolone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.161

7 January 2021